IP Library Patent Application 11286719
Patent Application
App. No. 11/286,719

Direct DNA delivery to bone cells

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/286,719
Abstract

An method is described that enables in vivo delivery of polynucleotides to cells of a mammalian bone limb. The method involves the injection of polynucleotides in a large volume into the lumen of the bone.

Claims (13)

1 . A method for delivering a polynucleotide to a bone cell in a mammal comprising: injecting into the lumen of said bone a solution containing said polynucleotide.

2 . The method of claim 1 wherein the solution is injected under pressure.

3 . The method of claim 1 wherein the bone cell is selected from the group consisting of: osteocyte, osteoclast, osteoblast, osteogenic progenitor cell, bone marrow cell, mesenchymal stem cell, multipotent adult progenitor cell, and stromal cells.

4 . The process of claim 1 wherein the cell is located in periosteum tissue of said bone.

5 . The process of claim 1 wherein injecting said solution results in increased permeability of veins in said bone.

6 . The process of claim 1 wherein the polynucleotide is a naked polynucleotide.

7 . The process of claim 1 wherein the polynucleotide comprises of an gene expression vector.

8 . The process of claim 1 wherein the polynucleotide comprises RNA.

9 . The process of claim 1 wherein the polynucleotide comprises DNA.

10 . The process of claim 1 wherein the polynucleotide is selected from the group consisting of siRNA, mRNA, mRNA and antisense RNA.

11 . The process of claim 1 wherein the polynucleotide is associated with a transfection reagent.

12 . The process of claim 1 wherein the polynucleotide encodes an osteogenic factor.

13 . The process of claim 12 wherein the osteogenic factor consists of a bone morphogenic protein.

Assignments (2)
CHANGE OF NAME Recorded Aug 10, 2009
From: MIRUS BIO CORPORATION
To: ROCHE MADISON INC.
Reel/Frame 023081/0128 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 27, 2008
From: SUBBOTIN, VLADIMIR; HEGGE, JULIA
To: MIRUS BIO CORPORATION
Reel/Frame 021446/0706 →